Inhibikase Therapeutics, Inc. (IKT) Description, Stock price, News & Info.
#ThinkSabio Latest News Inhibikase Therapeutics Announces Pricing of $110 Million Private Placement to Advance IkT-001Pro,...
#ThinkSabio Latest News Inhibikase Therapeutics Announces Pricing of $110 Million Private Placement to Advance IkT-001Pro,...
#ThinkSabio Latest News NeuroSense Therapeutics Plans to File for Early Commercialization of ALS Treatment in...
#ThinkSabio Latest News Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral...
#ThinkSabio Latest News E-Home Household Services Holdings Limited intends to merge and acquire an AI...
#ThinkSabio Latest News VCI Global Unleashes Enterprise AI Solutions with V-Gallant, Leveraging NVIDIA’s Computing Infrastructure
#ThinkSabio US Market Morning Brief Pre-Market Gainers $WW + 44%: WeightWatchers Adds Compounded GLP-1, Expanding...
#ThinkSabio Trending Stocks Gainers: #CSLD $WW $ALTM $STKH $HELE $INTR $TC $SRFM $ALAB $SAR Penny...
#ThinkSabio Viking Therapeutics, Inc. (VKTX), Inc. Success Story
#ThinkSabio Latest News Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s...
#ThinkSabio Latest News Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and...